SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE:KCI), a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces, today announced the acute phase results of a randomized, controlled, clinical trial (RCT) on the use of KCI’s V.A.C.® Therapy in the treatment of complex diabetic foot ulcers where the use of V.A.C. Therapy resulted in the following benefits:
